GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate hydroxymethyltransferase (B2JGD9)

Analyse AlphaFold monomer V2.0 prediction for 3-methyl-2-oxobutanoate… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2JGD9
Type
protein
Length
271 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x13Ce7B1602F31C98a611319cB5cA24DCD906Ba7F
Molecule
3-methyl-2-oxobutanoate hydroxymethyltransferase
UniProt
B2JGD9
Pockets
2 · best druggability 0.66

Structure

1 distinct chain · 42% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3-methyl-2-oxobutanoate hydroxymethyltransferaseprotein27142% helix, 14% strandB2JGD9

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12530.660.8236empty
2590.300.7522empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.